← Back to Search

Epic Best Practice Alert for Bacterial Infection

N/A
Waitlist Available
Led By Sayon Dutta, MD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All adult patients (>= 18 years old) who are seen in a Mass General Brigham Emergency Department who had a specific anchor antibiotic administered
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, up to 1 year
Awards & highlights

Study Summary

This trial is testing whether or not a Best Practice Alert in Epic (BPA) reminding physicians to re-order the antibiotic will increase the rate of ordering subsequent doses of antibiotics on-time and with the correct dosages.

Eligible Conditions
  • Bacterial Infection
  • Alert Fatigue
  • Sepsis

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, up to 1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, up to 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Delay Time to Next Antibiotic Dose
Secondary outcome measures
Admission to Intensive Care Unit (ICU)
Hospital Length-of-stay
In-hospital mortality

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Active Best Practice AlertExperimental Treatment1 Intervention
Care providers taking care of these patients will receive a Best Practice Alert (BPA) in the electronic medical record (EMR) one hour before an antibiotic expires with no subsequent doses ordered. The BPA will prompt the care provider to re-order the antibiotic and give information on recommended dosage and frequency based on indication and patient characteristics.
Group II: Inactive Best Practice AlertActive Control1 Intervention
The Best Practice Alert described in the Experimental Arm will not be active for patients in this arm. Care providers will proceed with usual care.

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalLead Sponsor
2,932 Previous Clinical Trials
13,198,075 Total Patients Enrolled
Sayon Dutta, MDPrincipal Investigator - Massachusetts General Hospital
Massachusetts General Hospital, Massachusetts General Physicians Organization Inc, North Shore Medical Center-Salem Hospital, North Shore Medical Center-Union Hospital
Loyola University Of Chicago Stritch School Of Medicine (Medical School)
Brigham & Women'S Hospital (Residency)

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Effect of BPA on Anchor Antibiotic Continuity in the ED: Randomized Controlled Trial
Sayon Dutta, MD 2020. "Effect of BPA on Anchor Antibiotic Continuity in the ED: Randomized Controlled Trial". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04620486.
~93 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top